21 – 23 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2006
-
Mark
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet (R)/Dovobet (R)/Taclonex (R)) in the treatment of psoriasis vulgaris
(
- Contribution to journal › Article
-
Mark
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet((R))/Daivobet((R))/Taclonex((R))) in the treatment of psoriasis vulgaris
(
- Contribution to journal › Article
- 2004
-
Mark
Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »